Sinopharm Group Co. Ltd.

SZSC:1099 Stock Report

Market Cap: HK$63.2b

Sinopharm Group Future Growth

Future criteria checks 1/6

Sinopharm Group is forecast to grow earnings and revenue by 6.3% and 6.1% per annum respectively. EPS is expected to grow by 6.5% per annum. Return on equity is forecast to be 6.3% in 3 years.

Key information

6.3%

Earnings growth rate

6.5%

EPS growth rate

Healthcare earnings growth21.6%
Revenue growth rate6.1%
Future return on equity6.3%
Analyst coverage

Good

Last updated31 Oct 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

SZSC:1099 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026698,27610,02612,70613,06214
12/31/2025650,5449,22312,28612,43216
12/31/2024599,1018,17421,34415,57512
9/30/2024593,0738,2366,8119,125N/A
6/30/2024590,3468,65316,76819,506N/A
3/31/2024598,3188,8848,03510,385N/A
12/31/2023596,5709,05414,88917,173N/A
9/30/2023591,6868,76510,52612,722N/A
6/30/2023591,6268,9369,66011,931N/A
3/31/2023570,0678,68814,46916,763N/A
12/31/2022552,1488,52618,64820,964N/A
9/30/2022546,1477,9146,1598,507N/A
6/30/2022533,4037,8704922,783N/A
3/31/2022528,3837,9705,3787,658N/A
12/31/2021521,0517,7597,0819,308N/A
9/30/2021510,0917,9304,5116,795N/A
6/30/2021501,7707,8748,74310,983N/A
3/31/2021482,2817,5915,8337,950N/A
12/31/2020456,4157,1879,09911,155N/A
9/30/2020440,1946,6155,9988,075N/A
6/30/2020427,3726,1742,3044,522N/A
3/31/2020424,4945,9186,5108,813N/A
12/31/2019425,2736,25116,41718,777N/A
9/30/2019406,3946,311-52,113N/A
6/30/2019382,7176,012-2241,744N/A
3/31/2019360,7606,087-5,010-3,011N/A
12/31/2018344,5265,8343923,654N/A
9/30/2018336,1135,523-9,906-6,868N/A
6/30/2018334,0605,606N/A2,882N/A
3/31/2018318,4145,083N/A-6,249N/A
12/31/2017308,3545,572N/A3,209N/A
9/30/2017288,8555,217N/A-19N/A
6/30/2017269,3564,861N/A-3,247N/A
3/31/2017264,6914,996N/AN/AN/A
12/31/2016258,3884,635N/A9,258N/A
9/30/2016251,4014,515N/A11,117N/A
6/30/2016244,4144,394N/A12,975N/A
3/31/2016234,4993,885N/AN/AN/A
12/31/2015228,6733,772N/A13,412N/A
9/30/2015222,5133,548N/A9,472N/A
6/30/2015216,3533,323N/A5,533N/A
3/31/2015207,8653,037N/AN/AN/A
12/31/2014200,1312,875N/A5,561N/A
9/30/2014190,8832,719N/A5,747N/A
6/30/2014181,6352,564N/A5,933N/A
3/31/2014174,2512,407N/A5,437N/A
12/31/2013166,8662,250N/A4,941N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 1099's forecast earnings growth (6.3% per year) is above the savings rate (2.3%).

Earnings vs Market: 1099's earnings (6.3% per year) are forecast to grow slower than the Hong Kong market (11.7% per year).

High Growth Earnings: 1099's earnings are forecast to grow, but not significantly.

Revenue vs Market: 1099's revenue (6.1% per year) is forecast to grow slower than the Hong Kong market (7.8% per year).

High Growth Revenue: 1099's revenue (6.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 1099's Return on Equity is forecast to be low in 3 years time (6.3%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y